Search Results (592)

UV-C light is a promising non-thermal technology for microbial inactivation on food surfaces; however, its efficacy may be compromised by the spatial structure of microbial colonies. The present work investigated the influence of Listeria monocytogenes colony size on UV-C treatment effectiveness using agar-based model systems. Petri dishes were inoculated at defined concentrations and incubated to generate colonies of varying sizes, which were subsequently exposed to a UV-C dose of 0.12 J/cm². Colony growth was monitored over 48 h using an image-based analysis workflow implemented in MATLAB, combined with individual colony tracking. A neural network model was developed to predict the probability of growth cessation based on colony diameter, and quantitative PCR combined with bead-beating was used to estimate cell counts per colony. UV-C treatment applied immediately after inoculation achieved high inactivation efficacy, consistent with minimal cell aggregation. As colony size increased, treatment effectiveness declined markedly. Bootstrap analysis of the neural-network predictions identified a minimum mean growth cessation probability at a colony diameter of approximately 0.862 mm. At this diameter, the predicted probability was 56.8%, with a pointwise 95% bootstrap interval of 50.3–62.8%, corresponding to approximately ${10}^{6.14}$ (viable + non-viable) cells per colony. These findings demonstrate that colony spatial structure substantially limits UV-C efficacy and underscore the importance of early-stage intervention in food surface UV-C decontamination protocols. Full article

Focused-ion-beam scanning electron microscopy (FIB-SEM) provides site-specific access to buried interfaces, particle interiors, porous electrode architectures, and localized degradation regions in energy materials. This capability is particularly valuable for rechargeable batteries, solid-state ion conductors, alkali-metal electrodes, and reactive solid–liquid interfaces, where the structures governing transport and failure are rarely exposed at a free surface. However, the preparation and imaging steps that reveal these regions may also alter them. Ion milling, environmental transfer, vacuum exposure, scanning electron microscopy (SEM), cryogenic handling, transmission electron microscopy (TEM), scanning transmission electron microscopy (STEM), energy-dispersive X-ray spectroscopy (EDS), electron energy-loss spectroscopy (EELS), and atom probe tomography (APT) can each modify local morphology, chemistry, or phase state. These effects are especially important when the intended evidence involves light elements, metastable phases, nanoscale coatings, reactive interphases, volatile species, or ion-conducting materials. This perspective develops a claim-specific framework for evaluating such results. Preparation- and imaging-induced changes are related to the material feature being interpreted and to the minimum control needed to distinguish the two origins. For porous electrodes, the relevant outputs include pore volume, connectivity, tortuosity, crack geometry, phase fraction, and active surface area. For reactive interfaces and solid electrolytes, the critical questions concern alkali-metal redistribution, surface amorphization, light-element contrast, implanted-species chemistry, and beam-induced phase formation. The discussion further compares conventional Ga-FIB, cryogenic FIB, Xe plasma FIB, low-energy Ar+ polishing, broad-ion-beam preparation, ultramicrotomy, and repeated particle-oriented FIB workflows. Reliable interpretation requires the preparation route, transfer conditions, imaging dose, analytical acquisition, and claim-specific controls to be reported together with the final microscopy result. Full article

To address the risks of cross-border transmission of pathogenic microorganisms posed by the failure or non-compliance of shipboard ballast water treatment systems, ports urgently require efficient and flexible emergency response solutions. This study presents a novel, containerized, integrated ship-to-shore emergency response system specifically designed for the rapid inactivation of pathogenic microorganisms in ballast water. The core innovation lies in the integration of a three-degree-of-freedom (3-DOF) hydraulic robotic arm, a vision and positioning system, and a dynamic inflatable sealing structure designed for rapid, automated docking with a ship’s ballast water discharge outlet (DN250), thereby enhancing operational safety and efficiency. The system employs a purely physical treatment process of “ultrasound (US) pre-treatment + dual-stage ultraviolet (UV) disinfection,” allowing for reception and treatment without secondary chemical pollution. The integrated treatment train, consisting of US (30 kHz, 7.6–12 kW, minimum acoustic energy density ≥ 0.45 J/cm²) followed by dual-stage UV disinfection (minimum UV dose: 147 mJ/cm²), maintained effective microbial inactivation at turbidity levels of 15, 125, 250, and 500 NTU. US alone showed little direct bactericidal effect, whereas the first UV stage achieved log reduction values (LRVs) of 3.31–4.13, and the complete US + UV + UV process achieved total LRVs of 5.07–7.34 for Escherichia coli. The results showed that dual-stage UV disinfection was key to achieving high inactivation efficacy (p < 0.001), while ultrasound, despite its limited direct bactericidal effect, may have facilitated downstream UV disinfection within the sequential treatment train. This system not only fills a critical gap in port biosecurity emergency infrastructure but also provides an experimentally validated, efficient, environmentally friendly, and flexibly deployable shore-based solution. Full article

Phycocyanin, a phycobiliprotein derived from the cyanobacterium Limnospira (Arthrospira) platensis (commonly known as Spirulina), is recognized for its antioxidant, immunomodulatory, and bioactive properties. This research aims to develop a new cosmetic ingredient based on phycocyanin incorporated into a high-lipid matrix, such as shea butter. A comprehensive characterization of the cytotoxicity and anti-inflammatory activity of this new bioactive phycocyanin–protein complex in human THP-1 monocytic cells was performed. For this purpose, cytocompatibility was evaluated using MTT assays at concentrations ranging from 10 to 0.0006% v/v. Anti-inflammatory activity was measured under LPS-induced inflammatory stress by measuring IL-6 and IL-8 secretion using ELISA in PMA-differentiated THP-1 cells treated with non-cytotoxic concentrations (0.04, 0.02, and 0.01% v/v). A crucial finding was the absence of anti-inflammatory activity at 0.01% v/v, indicating a minimum effective concentration threshold and, consequently, effective doses. The results of this research indicate that the phycocyanin and shea butter ingredients demonstrate strong cytocompatibility at relevant cosmetic doses and significant anti-inflammatory activity, supporting their suitability for formulations targeting skin sensitivity, erythema reduction, and post-inflammatory recovery. Full article

Bacterial cellulose (BC) is an emerging biopolymer for skin tissue regeneration; however, its functionalization with natural antimicrobial agents remains limited. This study reports the preclinical evaluation of a BC-based dressing for diabetic wounds. BC membranes were obtained from mango pulp agro-waste by Komagataeibacter xylinus cultivation (6.32 g/L) and functionalized with grapefruit seed oil (GSO) at three v/v ratios (1:100, 1:200 and 1:500). FTIR spectroscopy confirmed GSO incorporation into the BC matrix through physical interactions, with a dose-dependent loading. Antimicrobial activity of the BC/GSO dressings was screened against Staphylococcus aureus, Escherichia coli and Candida albicans by agar diffusion, showing dose-dependent inhibition zones. Following the minimum effective dose principle, the BC/GSO 1:500 (v/v) formulation was selected for comprehensive biocompatibility evaluation (cytotoxicity, mutagenicity, pyrogenicity and sensitization) and for in vivo wound-healing testing in a streptozotocin-induced diabetic Wistar rat model. Cell viability above 70% was achieved from membrane-extract dilution 1:100,000, while mutagenicity, pyrogenicity and sensitization assays confirmed the absence of adverse biological responses. In vivo, BC/GSO 1:500 (v/v) dressings supported wound closure comparable to nitrofurazone, with no clinical signs of infection. Overall, these results position BC/GSO dressings as a sustainable, biocompatible and antimicrobial candidate for early-stage diabetic wound regeneration and demonstrate the technical feasibility of valorizing mango pulp agro-waste into a high-value biomedical biopolymer. Full article

Antibiotic resistance and biofilm-associated infections require sustainable antimicrobial platforms that combine efficacy with biocompatibility. Fermented matrices are attractive for green nanomaterial production because they provide reducing metabolites and surface-active capping compounds. Rooibos kombucha is a polyphenol-rich fermentation system with potential to serve as a biosynthetic matrix for silver nanoparticles (AgNPs). The present work aimed to develop a rooibos kombucha-enabled platform for the green biosynthesis of phytochemical-capped silver nanoparticles, AgNPs-K, and evaluate their antibacterial, antibiofilm, and in vivo activity. Rooibos kombucha was fermented for 14 days and profiled by liquid chromatography–tandem mass spectrometry (LC–MS/MS). AgNPs-K were generated using kombucha extract and AgNO₃, purified, and characterized by ultraviolet–visible spectroscopy (UV–Vis), transmission electron microscopy (TEM), Fourier-transform infrared spectroscopy (FTIR), and nanoparticle tracking analysis. Antibacterial activity against eight Gram-positive and Gram-negative reference pathogens was assessed by EUCAST-based microdilution and time-kill assays. Biofilm inhibition was measured by the crystal violet assay. In vivo toxicity and therapeutic efficacy were evaluated in Galleria mellonella larvae. AgNP formation was confirmed by a surface plasmon resonance (SPR) peak at 415 nm. TEM showed predominantly spherical nanoparticles with a main size range of 20–30 nm, a hydrodynamic diameter of 98 nm, and a zeta potential of −14.62 ± 0.04 mV. AgNPs-K showed overlapping minimum inhibitory concentration and minimum bactericidal concentration values of 1.14 µg/mL for Gram-positive species and 1.33 µg/mL for Gram-negative species. Time-kill assays showed rapid bactericidal activity after threshold concentrations were reached, with sustained suppression at 24 h. Biofilm formation was abolished at 40 µg/mL and strongly reduced at lower concentrations. AgNPs-K were non-toxic up to 400 µg/mL and improved survival in six of seven infection models. Fermented rooibos kombucha functions as an effective biosynthetic matrix for the green production of phytochemical-capped AgNPs. The resulting nanoparticles combine low-dose antibacterial and antibiofilm activity with favorable in vivo tolerability and efficacy, supporting fermentation-enabled nanobiotechnology strategies against biofilm-associated infection. Full article

Background/Objectives: Wound infections represent a major clinical challenge due to their polymicrobial nature, biofilm formation, and increasing antimicrobial resistance, which compromise conventional treatments. This study aimed to develop and evaluate ligand-stabilized silver nanoparticles (AgNPs) with improved antimicrobial activity and cytocompatibility, and to investigate their incorporation into electrospun nanofibers for wound management. Methods: Four AgNP formulations stabilized with citrate, cysteine, ketorolac, and diclofenac were synthesized via chemical reduction. Physicochemical characterization included surface plasmon resonance and zeta potential measurements. Antimicrobial activity was assessed through minimum inhibitory concentration (MIC) and bactericidal assays against Gram-positive, Gram-negative, and fungal strains. Toxicity was evaluated using the HET-CAM assay, while cytocompatibility was determined in fibroblasts, MG-63 cells, and mesenchymal stem cells. Diclofenac-stabilized AgNPs were incorporated into electrospun PCL/PEO nanofibers to generate a functional nanocomposite system. Results: All AgNPs exhibited a characteristic SPR at ~400 nm and high colloidal stability. Diclofenac-stabilized AgNPs (dc-AgNPs) showed the highest antimicrobial activity, with MIC values of 18.8 mg/L against Staphylococcus aureus and Pseudomonas aeruginosa, and 4.7 mg/L against Candida albicans, along with strong bactericidal effects. HET-CAM assays indicated negligible irritation at concentrations up to 75 mg/L. Cytocompatibility results revealed a dose-dependent response, with fibroblasts being more sensitive. Electrospun nanofibers loaded with dc-AgNPs achieved a 2.6 log reduction against Streptococcus mutans and moderate reductions (0.4–0.7 log) against other pathogens. Conclusions: Ligand engineering critically influences the antimicrobial efficacy and biocompatibility of AgNPs. The incorporation of dc-AgNPs into electrospun nanofibers represents a promising approach for treating biofilm-associated wound infections. Full article

Gallium oxide (Ga₂O₃) is emerging as a promising material for X-ray detectors due to its high sensitivity, high melting point, and stable physicochemical properties. However, intrinsic background shallow donors in raw materials hinder the preparation of high-resistance intrinsic crystals, making doping essential to tailor electrical properties. This study grew Ti³⁺-doped β-Ga₂O₃ single crystals via the Edge-defined Film-fed Growth (EFG) method using Ti₂O₃ as a dopant, achieving high resistivity and a moderate reduction in bandgap. High-resolution X-ray diffraction (HRXRD) showed a rocking curve full width at half maximum (FWHM) of 96.50 arcsec. Compared with the unintentionally doped (UID) crystal, the bandgap exhibited a slight reduction, decreasing from 4.76 eV to 4.59 eV. In the infrared transmission spectra, the onset wavelength of the decrease in transmittance for the Ti³⁺: β-Ga₂O₃ crystal showed a distinct redshift relative to that of the UID crystal, indicating effective suppression of free electrons within the crystal. X-ray photoelectron spectroscopy (XPS) revealed that Ti³⁺ incorporation minimally affected the valence states of Ga and O or the Ga/O ratio, with no significant shift in valence band maximum (EVBM). A metal–semiconductor–metal (MSM) structured X-ray detector fabricated on polished Ti³⁺: β-Ga₂O₃ (100) substrate with Ti/Au electrodes exhibited a peak sensitivity of 943.16 μC/(Gy·cm²) at 40 V bias and 2.944 μGy/s dose rate, surpassing the upper sensitivity limit reported for semi-insulating doping bulk β-Ga₂O₃ detectors. The rise and fall times were 0.23 s and 0.30 s, respectively, with a minimum detectable limit (MDL) of 164.26 nGy/s, demonstrating its potential for high-performance X-ray detection applications. Full article

Background/Objectives: Chronic low back pain (CLBP) affects approximately 20% of the global population and is a leading cause of years lived with disability. Long-term, real-world evidence for inhaled cannabis in patients refractory to conventional multimodal therapy remains scarce. We assessed the five-year efficacy and safety of inhaled cannabis in CLBP patients who had documented failure of ≥1 year of opioid analgesics, anticonvulsants, antidepressants, NSAIDs, and physiotherapy, with each patient serving as their own historical control. Methods: We analyzed prospectively collected clinical data from 241 consecutive adults with treatment-refractory CLBP (mean age 49.3 ± 14.9 years; 37.8% female; mean pain duration 15.1 years) initiated on inhaled medical cannabis (predominantly smoking, THC 4–22%, CBD 2–22%) in a single-center tertiary orthopedic clinic between 2020 and 2025 (Hasharon Hospital, Rabin Medical Center, Israel; IRB protocols 0807-21-RMC and 0634-25-RMC). Year-0 outcomes during conventional therapy were compared with outcomes at Years 1–5 on cannabis. Primary outcomes were the Numeric Rating Scale (NRS), Oswestry Disability Index (ODI), and Brief Pain Inventory severity/interference (BPI-S/BPI-I). Concomitant-medication trajectories were a secondary outcome. The primary analysis was a mixed model for repeated measures (MMRM) with random intercept and slope, REML estimation, and time as a categorical fixed effect. Multiple imputation (MAR, m = 20, Rubin’s rules) was the primary missing-data approach; complete-case and tipping-point pattern-mixture sensitivity analyses were used. A multivariate Hotelling T² provided a joint test across the four correlated PROMs. Concomitant-medication discontinuation was modeled with GEE logistic regression and exact McNemar tests. Time to discontinuation was estimated by Kaplan–Meier and Cox regression. The Bonferroni-adjusted significance threshold for the four primary outcomes was α = 0.0125. BioWell gas-discharge-visualization (GDV) parameters were exploratory only. Results: Of 241 patients, 238 (98.8%) provided Year-5 data and 224 (92.9%) remained on cannabis at Year 5; only five patients (2.1%) discontinued for adverse events or inefficacy. All four primary PROMs improved markedly and durably. MMRM-estimated Year-5 minus Year-0 changes were: NRS −5.36 (95% CI −5.65, −5.07), ODI −17.68 (95% CI −19.73, −15.63), BPI-S −6.73 (95% CI −6.99, −6.47), and BPI-I −3.41 (95% CI −3.65, −3.16); all four contrasts had |z| ≥ 16.9 and p < 10⁻²⁰. MI-pooled estimates were within 0.05 of MMRM (FMI < 0.03 for all outcomes). Hotelling T² was F(4, 232) = 872.8, p < 10⁻²⁰. At Year 5, 89.2% achieved ≥30% NRS reduction, 77.2% ≥ 50%, and 93.4% met the NRS minimum clinically important difference (MCID); ODI MCID 65.6%, BPI-S MCID (≥1 pt) 98.3%, BPI-I MCID (≥1 pt) 91.3%. Concomitant opioid use fell from 100% at baseline to 4.6% at Year 5 (within-patient absolute risk reduction 95.4%, McNemar exact p = 1.16 × 10⁻⁶⁹), NSAID from 100% to 7.1%, SSRI/SNRI from 80.5% to 5.4%, and gabapentinoid from 38.6% to 2.5%. The ARR-derived NNT for opioid discontinuation was 1.05; this NNT is referenced to each patient’s own documented maximal-conventional-therapy state and is not equivalent to a between-arm randomized-trial NNT. Cannabis dose × time interaction was consistent with no pharmacological tolerance (β = −0.0044 per gram-month per year, p = 0.074). Across 1205 patient-years of cannabis exposure (calculated as 241 patients × 5 follow-up years from Year 1 through Year 5; baseline Year 0 represents pre-cannabis state and is not included in person-time on cannabis), 1338 organ-system AE events were recorded at 1.110/patient-year (Poisson 95% CI 1.05–1.17); 99.8% of graded events were mild (grade 1), with ocular (476 events, 0.40/PY), cognitive (460, 0.38/PY), and gastrointestinal (368, 0.31/PY) reactions predominating. The Year-3 retention dip reflected a documented telemedicine-clinic phenomenon during 2022–2024, with patients returning to in-person follow-up by Year 4–5. BioWell GDV discriminated NRS ≥ 4 only at chance level (BWS AUC 0.574, 95% CI 0.54–0.60; BWV AUC 0.51). Conclusions: In a treatment-refractory CLBP cohort with five-year longitudinal follow-up, inhaled cannabis was associated with large, sustained, and statistically robust improvements in pain, disability, and pain interference, accompanied by near-total displacement of opioids, NSAIDs, antidepressants, and gabapentinoids. These observational associations, although mechanically less susceptible to bias for the binary medication-discontinuation outcomes than for self-reported PROMs, cannot be interpreted causally in the absence of a concurrent randomized control arm and may reflect a combination of pharmacological effect, regression to the mean from a high pre-treatment baseline, expectancy and self-selection effects intrinsic to an actively chosen open-label therapy, and secular trends in pain reporting. The within-patient benefit-risk profile—ARR-derived NNT ≈ 1 for opioid sparing against a predominantly mild adverse-event burden—supports consideration of cannabis as a potentially clinically meaningful, opioid-sparing option in patients who have failed multimodal conventional therapy, pending confirmation in randomized comparative trials. Full article

As chronic lead (Pb) exposure is a serious threat to public health in many countries, we intended to provide a review of the effective antidote for Pb intoxication. In this context, we explored the recent literature focusing on animal studies that provide clear evidence of the efficacy of supplementation with certain antioxidants, such as spirulina, curcumin, garlic, vitamin C, and vitamin E, for different periods of time, in the conditions of Pb exposure, drawing attention to the mechanisms of their beneficial action. Data collected clearly indicate that spirulina, curcumin, garlic, vitamin C, and vitamin E may play an important role in alleviating some of the toxic effects caused by Pb. Their use may represent an interesting direction in the development of new therapies to combat the toxicity of this toxic, non-essential metal. However, it seems essential to identify a safe dose range for these antioxidants in order to derive benefits from their properties during Pb intoxication. Clinical trials seem to be necessary to recognize the long-term effects of supplementation with these antioxidants and to establish the minimum effective dose with minimal side effects. Future studies are also required to elucidate the molecular mechanisms of action of spirulina, curcumin, garlic, vitamin C, and vitamin E against Pb toxicity and the mechanisms of their interactions with chelating agents to enhance potential beneficial effects. Full article

Background: Plant essential oils are extensively utilized for their antimicrobial properties; however, the specific antifungal mechanisms of certain compounds are not well characterized. Geraniol, a naturally occurring monoterpene alcohol approved for use in foods, demonstrates potential efficacy against spoilage fungi, yet detailed mechanistic insights are lacking. Methods: In this study, we determined the minimum inhibitory concentration (MIC) and minimum fungicidal concentration (MFC) of geraniol against P. polonicum. We assessed the underlying mechanisms by evaluating membrane integrity, intracellular leakage, reactive oxygen species (ROS), antioxidant enzymes (superoxide dismutase [SOD], peroxidase [POD], catalase [CAT]), malondialdehyde (MDA) levels, ATP content, and ATPase activity. Inoculated yam slices were exposed to geraniol vapor, and we monitored sensory, physicochemical, enzymatic, and microbial parameters. Results: Geraniol exhibited a minimum inhibitory concentration/minimum fungicidal concentration (MIC/MFC) of 0.3 mL/L. It disrupted cellular membranes, induced leakage, generated ROS, and caused lipid peroxidation, leading to elevated levels of malondialdehyde (MDA). Additionally, geraniol activated antioxidant enzymes and impaired energy metabolism. Fumigation with geraniol dose-dependently delayed the deterioration of yam, reduced weight loss, preserved texture and color, inhibited polyphenol oxidase (PPO) and POD activities, enhanced CAT and SOD activities, lowered MDA levels, and suppressed bacterial growth. Conclusions: Geraniol inhibits P. polonicum through multiple mechanisms, including membrane disruption, oxidative stress, and interference with energy metabolism, thereby effectively preserving the quality of fresh-cut yam and demonstrating potential as a natural preservative. Full article

Sparassis crispa (cauliflower mushroom) is an edible medicinal fungus known for its diverse array of bioactive metabolites. Despite its established nutritional and pharmacological relevance, its antimicrobial, antiviral, and antiparasitic activities remain insufficiently investigated. In the present study, extracts of the fruiting bodies of S. crispa were prepared using four solvents (water, 60% ethanol, methanol–acetone–water [3:1:1], and 1% acetic acid) and evaluated for their chemical composition and broad-spectrum biological activities. UHPLC-MS/MS profiling revealed distinct metabolite profiles among the extracts, including identification of nucleosides such as adenosine and methylthioadenosine. All extracts exhibited nematicidal activity against Rhabditis sp. nematodes in a dose-dependent manner, with the 60% ethanol extract being the most potent (LD₅₀ = 4.2 mg/mL). In antiviral assays, the water extract partially inhibited Coxsackievirus B3 (CVB3) replication, reducing infectious titers by approximately 2 log units, whereas none of the extracts showed a significant effect against Herpes simplex virus type 1 (HSV-1). Antibacterial testing demonstrated activity only for the 1% acetic acid extract, which inhibited several Gram-positive and Gram-negative bacteria at minimum inhibitory concentrations of 10–20 mg/mL. No antifungal activity against Candida spp. was observed. These findings identify Sparassis crispa as a promising edible source of bioactive compounds, exhibiting pronounced nematicidal and moderate antimicrobial activities, and support its potential application in the development of functional foods and nutraceuticals. They further justify targeted isolation and mechanistic studies to characterize the metabolites responsible for these effects and to clarify their relevance for food-based health promotion. Full article

Background/Objectives: Natamycin is an effective antifungal limited by poor solubility. This study aimed to develop and characterize natamycin-loaded liposomal vesicles as a biocompatible delivery system to improve stability and achieve controlled release for potential topical application in the treatment of fungal infections. Methods: Formulations were prepared using two phospholipid mixtures (Lipoid S100 and Phospholipon 90H) via standard (thin-film) and proliposome methods. Evaluation included encapsulation efficiency (EE%), particle size, zeta potential, the polydispersity index (PDI), and rheological properties. In vitro release kinetics were compared to a natamycin solution. Antifungal efficacy was tested against four Candida strains to determine minimum inhibitory and fungicidal concentrations (MICs and MFCs, respectively) and biofilm inhibition, while biocompatibility was assessed via keratinocyte viability assays. Results: Formulations achieved high encapsulation (~90%). Natamycin incorporation improved homogeneity and reduced particle diameters, particularly in proliposome-derived vesicles, suggesting strong drug–lipid interactions. Preparation method and lipid type significantly influenced properties; thin-film formulations showed a lower PDI and higher stability. Diffusion was twofold slower than the control, with Lipoid S100 proliposomes providing the most sustained release. The liposomes demonstrated robust antifungal activity (MICs: 0.00625–0.2 mg/mL) and effective biofilm inhibition against C. krusei. While high concentrations moderately reduced keratinocyte viability, lower doses remained biocompatible and slightly stimulatory. Conclusions: Lipid composition and preparation methods have minimal impact on the physical properties and in vitro release profiles of natamycin liposomes. These vesicles provide a dose-dependent, biocompatible platform for the controlled delivery of antifungals, showing significant in vitro inhibitory activity against Candida growth and biofilm formation. Full article

Background: This study aimed to assess the impact of PSMA-PET/CT fusion imaging on target volume delineation in prostate cancer RT and to evaluate its effects on dosimetric parameters and PSA response, including intraprostatic boost. Methods: This single-center, retrospective study included 138 prostate cancer patients treated with definitive RT. Patients were evaluated according to the use of PSMA-PET/CT fusion-based planning and an intraprostatic focal boost, and dosimetric parameters for target volumes and organs at risk were compared. Results: PSMA-PET/CT fusion-based planning significantly increased the minimum dose coverage of the prostate target volume (96.7% vs. 95.5%, p = 0.003) while reducing the maximum dose (104.8% vs. 106.1%, p < 0.001). At 1 year after RT, the median change in PSA from baseline was 0.08 ng/mL (range, −0.44–2.12) in patients who underwent PSMA PET imaging-based fusion planning compared with 0.01 ng/mL (range, −0.049–4.07) in those who did not (p = 0.010). In patients receiving the intraprostatic focal boost with PSMA-PET/CT fusion, rectal maximum dose percentages were significantly lower than in those without the boost (103.2% [98.9–106.7] vs. 103.8% [95.7–107.4], p = 0.026). Rectal V65 and V50 values were also significantly reduced in the fusion group (7.0% [0.7–19.8] vs. 5.2% [1.2–21.7], p = 0.007; and 13.6% [6.3–21.9] vs. 11.4% [4.4–29.2], p = 0.027, respectively). Bladder maximum dose percentages were significantly lower in patients receiving the PSMA-PET/CT fusion-guided intraprostatic boost compared with those without the boost (102.6% [99.7–107.9] vs. 104.5% [99.1–108.5], p = 0.001). Conclusions: PSMA-PET/CT fusion-based planning improves biologically guided target delineation and dose homogeneity and suggests potential for better early biochemical response while reducing normal tissue exposure, whereas the intraprostatic focal boost improves dose distribution but is not associated with a significant short-term (1-year) PSA benefit. Full article

This study aimed to develop a biotechnological process for producing a lactic-fermented tomato ingredient (Solanum lycopersicum) capable of acting as a natural reddish colorant and enhancing microbiological stability in fresh pork sausage, reducing dependence on cochineal carmine, whose market price has fluctuated substantially. The bioprocess was conducted at industrial scale using a 10% tomato flour solution subjected to enzymatic hydrolysis with pectinases to release lycopene, followed by co-culture fermentation with Lacticaseibacillus paracasei ATCC 25302 and Pediococcus acidilactici ATCC 8042 to convert sugars into lactic acid. The antimicrobial potential of the ingredient was assessed through minimum inhibitory concentration assays using the Computational Microbial Density Scanning method against microbiota isolated from fresh pork sausage. A dose-dependent inhibitory effect was observed, with significant growth reduction from 2%. The fermented ingredient was then applied at 2% (w/w) in fresh pork sausage, partially or fully replacing cochineal carmine. Instrumental color analysis showed that 2% enabled a 50% reduction in cochineal carmine without compromising color. Microbiological stability evaluated using the MicroLab_ShelfLife method revealed a substantial reduction in microbial growth rates in treated groups. Overall, lactic-fermented tomato can partially replace cochineal carmine while preserving sensory color and providing an antimicrobial function, thereby enhancing product stability and shelf-life. Full article